Tracking early cystic fibrosis in the new era

Pinelopi Anagnostopoulou1, Sandra Rovira-Amigo2,3

  • 1Medical School, University of Cyprus, Nicosia, Cyprus.

ERJ Open Research
|March 25, 2026
PubMed

Insights

Prospective studies are needed to understand how young children with cystic fibrosis (CF) develop during the new modulator therapy era. This research aims to provide a comprehensive overview of their growth and health outcomes.

Area of Science:

  • Pediatric Pulmonology
  • Genetic Diseases
  • Pharmacology

Background:

  • Cystic fibrosis (CF) is a genetic disorder affecting multiple organs.
  • CFTR modulator therapies have transformed treatment paradigms.
  • Long-term outcomes in young children under these new therapies are not well-documented.

Related Concept Videos